Virus-Specific T-Cell Sensitization. Requirements for vaccinia virus specific T cell sensitization in vivo. by Ertl, Hildegund et al.
Volume 4 1977 
Editorial Board 
Editor-in-chief 
GEORGE D . SNELL, Bar Harbor, Maine 
Managing Editor 
JAN K L E I N , Dallas, Texas 
Associate Editors 
B. BENACERRAF, Boston, Massachusetts 
H.O. M C D E V I T T , Stanford, California 
N . A . MITCHISON, London, U . K . 
J.W. U H R , Dallas, Texas 
D.W. BAILEY, Bar Harbor, Maine 
D. BENNETT, New York, New York 
J.D. CAPRA, Dallas, Texas 
N . COHEN, Rochester, New York 
J. DAUSSET, Paris, France 
P. DEMANT, Amsterdam, The Netherlands 
Μ. E D I D I N , Baltimore, Maryland 
J . K . EGOROV, Moscow, U.S.S.R. 
J. FORMAN, Dallas, Texas 
D . L . GASSER, Philadelphia, Pennsylvania 
D. GÖTZE, Philadelphia, Pennsylvania 
W.H. H I L D E M A N N , LOS Angeles, 
California 
N . HILSCHMANN, Göttingen, Germany 
P. I V Ä N Y I , Amsterdam, The Netherlands 
E. K L E I N , Stockholm, Sweden 
B.B. KNOWLES, Philadelphia, Pennsylvania 
F . M . KOURILSKY, Paris, France 
F. L I L L Y , New York, New York 
V. M I G G I A N O , Basle, Switzerland 
Ε. MOZES, Rehovot, Israel 
S.G. NATHENSON, New York, New York 
L. DUPASQUIER, Basle, Switzerland 
Κ . RAJEWSKY, Cologne, Germany 
Η. RAMSEIER, Zurich, Switzerland 
R.A. REISFELD, La Jolla, California 
M . SELA, Rehovot, Israel 
D.C. SHREFFLER, St. Louis, Missouri 
A .G. STEINBERG, Cleveland, Ohio 
H . WAGNER, Mainz, Germany 
N . L . WARNER, Albuquerque, New Mexico 
D.B. WILSON, Philadelphia, Pennsylvania 
R . M . ZINKERNAGEL, La Jolla, California 
0 Springer-Verlag New York Heidelberg Berlin 
Index 
Beals, T.F. : see Schultz, J.S. et al 315 
Beisel, K .W. : see Passmore, Η.C 393 
Benaceraff, Β. : see Cheung, N .K .V . et αί LöJ 
Benedict, A .A. , Pollard, L.W., and Maurer, P.H.: Genetic Control of Im-
mune Responses in Chickens I I . Responses to Methylated Bovine Serum 
A l b u m i n - p o l y ( G l u 6 0 A l a 3 0 T y r l > Aggregates 199 
Bertrams, J.: see Grosse-Wilde, H . et al. 481 
Bevan, M.J., and Hyman, R.: The Abil i ty of H - 2 + and H-2~ Cell Lines 
to Induce or be Lysed by Cytotoxic Τ Cells 7 
Black, G. : see Palm, J. et al 79 
Boyse, E.A.: see Flaherty, L. et al 101 
Boyse, E.A.: see Koo, G.C. et al 213 
Boyse, E.A.: see Sato, H . et al 591 
Brezin, C.: see Cazenave, P. et al 489 
Briles, D.E., Krause, R .M. , and Davie, J .M. : Immune Response Deficiency 
of BSVS Mice. I . Identification of Ir Gene Differences Between A/J 
and BSVS Mice in the Antistreptococcal Group A Carbohydrate Re­
sponse . 381 
Cazenave, P., Brezin, C , Puget, Α., and Mandy, W J . : Lagomorph-Constant 
Region IgG Allotypes: Shared e Determinants in Ochotona Sp. . . . 489 
Cherry, J.D.: see Spencer, M.J. et al. . > 365 
Cheung, N . K . V . , Dorf, Μ.Ε. , and Benacerraf, Β.: Genetic Control of the 
Primary Humoral Response to G lu 5 6 Lys 3 5 Phe 9 163 
Clark, E.A., and Hildemann, W . H . : Genetics of Graft-Versus-Host Reac­
tions I . Production of Splenomegaly and Mortality in Mice Disparate 
at H-21 Subregions 281 
Clark, E.A.: see Harmon, R.C. et al 601 
Cukrovä, V., Rychlikovä, M . , and Demant, P.: Defective M L R Capacita-
tion in the Human: Low Xenogeneic M L R Capacity Associated with 
H L A Antigens AW25 Β18, and DW2 531 
IV Index 
Davie, J .M. : see Briles, D.E. et al. . 381 
Demant, P.: see Cukrovä, Ν. etal 531 
Demant, P.: see Morello, D . et al 349 
DeMott-Friberg, R.: see Schultz, J.S. etal 315 
Dorf, M.E . : see Cheung, N . K . V . etal 163 
Dupont, B. : see Hansen, J.A. et al 327 
Edidin, M . : see Ostrand-Rosenberg, S. et al 127 
Elkins, W.L. , and Silvers, W . K . : Variable Effect of an H-21 Barrier on 
Response to Skin Allografts in the Mouse 245 
Ert l , H.C.J., Gerike, R.H.W., and Koszinowski, U . H . : Virus-Specific T-Cell 
Sensitization. Requirements for Vaccinia Virus-Specific T-Cell Sensitiza­
tion in vivo 515 
Figueroa, F.: see Pizarro, O. et al 57 
Flaherty, L. , Stanton, T .H. , and Boyse, E.A.: Contamination of la Antise­
rum A . T L a n t i - A T H with Antibodies Related to the Tla Region. . . 101 
Forman, J., and Klein, J.: Immunogenetic Analysis of H-2 Mutations V I . 
Crossreactivity in Cell-Mediated Lympholysis Between TNP-Modified 
Cells from H-2 Mutant Strains 183 
Friedrich, U . : see Zeuthen, J. et al 567 
Gamble, U.R.: see Vadas, M . A . etal 137 
Gerike, R.H.W.: see Ertl , H . C J . etal 515 
Gewürz, Η . : see Osofsky, S.G. et al 195 
Gladstone, P.: see Pious, O.etal . 437 
Good, R.A.: see Hansen, J.A. et al 327 
Götze, D . : see Nowack, H . et al 177 
Gregorovä, S., Ivänyi, P., Simonovä, D. , and Mickovä, M . : //-2-Associated 
Differences in Androgen-Influenced Organ Weights of A and C57BL/10 
Mouse Strains and their Crosses 301 
Grosse-Wilde, H . , Bertrams, J., Schuppien, W., Netzel, B., Ruppelt, W., 
and Kuwert, E.K.: H L A - D Typing in 111 Multiple Sclerosis Patients: 
Distribution of Four H L A - D Alleles 481 
Grosse-Wilde, H . : see Hauptmann, G. et al 557 
Grumet, F.C.: see Smith, S.M. etal 221 
Hammerberg, C.: see Ostrand-Rosenberg, S. et al 127 
Hansen, J.A., Dupont, B., L'Esperance, P., and Good, R.A.: Congenital 
Neutropenia: Abnormal Neutrophil Differentiation Associated with 
HLA 327 
Harmon, R.C., Clark, E.A., OToole, C , and Wicker, L.S.: Resistance 
of H-2 Heterozygous Mice to Parental Tumors. I . Hybrid Resistance 
and Natural Cytotoxicity to EL-4 Are Controlled by the H-2D-Hh-1 
Region 601 
Hasek, M . : see Holäh, V 155 
Haughton, G.: see Wettstein, P.J 65 
Hauptmann, G., Tongio, M . M . , Grosse-Wilde, H . , and Mayer, S.: Linkage 
Between C2 Deficiency and the Η LA-A10, B18, Dw2jBfS Haplotype 
in a French Family 557 
Helgesen, A . : see Kaakinen, A. etal 205 
Index V 
Heyner, S.: sse Zink, G.L 257 
Hildemann, W . H . : see Clark, E.A 281 
Holäfi, V., and Hasek, M . : Specificity of Cell-Mediated Transplantation 
Reactions in Rats Detected by the Macrophage Adherence Inhibition 
Test 155 
Hyman, R., and Stallings, V . : Analysis of Hybrids Between an H - 2 + , T L " 
Lymphoma and an H - 2 + , T L + Lymphoma and Its H-2" , T L ~ Variation 
Subline 171 
Hyman, R.: see Bevan, M.J 7 
Itakura, K . : see Sato, U. et al 591 
Ivänyi, P.: see Gregorova, S. et al 301 
Jackson, D.C., Parish, C.R., and McKenzie, I.F.C.: Detection and Isolation 
of an la Glycoprotein Antigen from Mouse Serum 267 
Kaakinen, Α., Helgesen, Α., Nousiainen, H . , Solheim, B.G., and Thorsby, 
E.: The H L A - D Determinants. A Population Study of Norwegians . . 205 
Kappler, J.W.: see Marrack, Ρ 541 
Keat, A.C. : see Pegrum, G.D. et al 523 
Kim, Y.T. , and Siskind, G.W.: Studies on the Control of Antibody Synthesis 
X. Selective Breeding of Rats for the Production of High-Affinity Anti ­
body 463 
Klein, E.: see Zeuthen, J. et al 567 
Klein, J.: see Forman, J 183 
Klein, J.: see Zinkernagel, R . M 581 
Kohn, H . I . : see McKenzie, I.F.C. etal 333 
Koo, G.C., M i t t l , L.R., and Boyse, E.A.: Antibody to Testicular Cells 
in the Serum of Normal Mice 213 
Koszinowski, U . H . : see Ertl , H.C.J, etal 515 
Krause, R . M . : see Briles, D.E. etal 381 
Kuwert, E.K.: see Grosse-Wilde, H . etal 481 
Lane, D.P.: see Silver, D . M 295 
Leslie, G.A.: see Stankus, R.P 233 
L'Esperance, P.: see Hansen, J.A. et al 327 
Lewis, C M . : see Pegrum, G.D. etal 523 
Lonai, P., and McDevitt, H.O.: The Expression of /-Region Gene Products 
on Lymphocytes I . Demonstration of M L R Determinants on Τ Cells . 17 
Lonai, P., and McDevitt, H.O.: The Expression of /-Region Gene Products 
on Lymphocytes I I . Genetic Localization and Cellular Distribution of 
M L R Determinants 33 
Mandy, W.J.: see Cazenave, Y.etal 489 
Marcy, S.M.: see Spencer, M.J. etal 365 
Marrack, P., and Kappler, J.W.: Anti- la Inhibits the Activity of Β Cells 
But Not a Τ Cell-Derived Helper Mediator 541 
Maurer, P.H.: see Benedict, A . A . etal 199 
Maurer, P .Η. : see Merryman, C.F. etal 373 
Mayer, S.: see Hauptmann, G. et al 557 
McDevitt, H.O. : see Lonai, Ρ 17, 33 
McKenzie, I . F . C , Morgan, G .M. , Melvold, R.W., and Kohn, H I . : BALB/ 
VI Index 
c-H-2db\ Α New H-2 Mutant in BALB/cKh that Identifies a Locus 
Associated with the D Region 333 
McKenzie, I . F . C : see Jackson, D . C et al 267 
Melvold, R.W.: see McKenzie, I.F.C. etal 333 
Merryman, C.F., Maurer, P.H., and Zeiger, A.R. : Genetic Control of Two 
Independently Segregating Loci in Mice to the Sequential Polypeptide 
(Tyr-Ala-Glu-Gly) n 373 
Mickey, M.R . : see Spencer, M.J. etal 365 
Mickovä, M . : see Gregorovä, S. et al 301 
Miller, J.F.A.P.: see Vadas, M . A . etal 137 
M i t t l , L.R.: see Koo, G.C. etal 213 
Mit ta l , K . K . : see Osofsky, S.G. etal 195 
Morello, D. , Neauport-Sautes, C , and Demant, P.: Topographical Rela-
tionships Among H-2 Specificities Controlled by the D Region . . . . 349 
Morgan, G . M . : see McKenzie, I.F.C. etal 333 
Murphy, G.: see Silvers, W.K. etal 85 
Neauport-Sautes, C.: see Morello, D. et al 349 
Ness, D.B.: see Smith, S.M. etal 221 
Netzel, B.: see Grosse-Wilde, H. et al 481 
Newton, R.C., and Warner, C M . : The Immune Response oflnbred Mouse 
Strains to DNP-BGG. 1. The Effect of Dose and Adjuvant 449 
Nousiainen, H . : see Kaakinen, h. et al 205 
Nowack, H . , Rohde, H . , Götze, D. , and Timpl, R.: Genetic Control and 
Carrier and Suppressor Effects in the Antibody Response of Mice to 
Procollagen 117 
Osofsky, S.G., Thompson, B.H., Gewürz, Η., Schmid, F.R., and Mitra l , 
K . K . : Evidence for Lack of Linkage Between H L A and C3 Deficiency 
in Man 195 
Ostrand-Rosenberg, S., Hammerberg, C , Edidin, M . , and Sherman, M . I . : 
Expression of Histocompatibility-2 Antigens on Cultured Cell Lines Deri­
ved from Mouse Blastocysts 127 
O-Toole, C.: see Harmon, R.C. et al . 601 
Palm, J., Rigiero, C , and Black, G.: Further Studies on the Number of 
Histocompatibility Loci in Rats 79 
Parish, C.R.: see Jackson, D.C. etal 267 
Passmore, H.C., and Beisel, K . W . : Preparation of Antisera for the Detection 
of the Ss Protein and the Sip Alloantigen 393 
Pegrum, G.D., Lewis, C M . , and Keat, A.C. : H L A Antigens Associated 
with the Lymphocyte Nucleus 523 
Pious, D. , Soderland, C , and Gladstone, P.: Induction of H L A Mutations 
by Chemical Mutagens in Human Lymphoid Cells 437 
Pizarro, O., Vergara, U . , and Figueroa, F.: A Study of Histocompatibility-2 
Antigens in Wi ld Mice from Santiago, Chile 57 
Pollard, L .W. : see Benedict, A .A . etal 199 
Poole, T.W.: see Silvers, W.K. etal 85 
Potter, M . : see Weigert, Μ. et al 401 
Index VII 
Powell, K . R . : see Spencer, M.J. etal 365 
Puget, A . : see Cazenave, P. et al 489 
Rajan, T .V. : H-2 Antigen Varients in a Cultured Heterozygous Mouse 
Leukemia Cell Line 105 
Rigiero, C.: see Palm, J. et al 79 
Rohde, H . : see Nowack, H . et al 117 
Rosen, A . : see Zeuthen, J. et al 567 
Ruppelt, W. : see Grosse-Wilde, H . et al 481 
Rychlikovä, M . : see Cukrovä, Y.etal 531 
Sato, H . , Itakura, K . , and Boyse, E.A.: Location of Lyb-2 on Mouse 
Chromosome 4 591 
Schmid, F.R.: see Osofsky, S.G. etal 195 
Schultz, J.S., Beals, T.F., and DeMott-Friberg, R.: Tissue Graft Rejection 
in Mice. I I . Graft Survival Across H-2 Regional Barriers 315 
Schuppien, W.: see Grosse-Wilde, H . et al 481 
Silver, D . M . , and Lane, D.P.: Identification of the Gene Locus Controlling 
Dominant Nonresponsiveness to F-Antigen 295 
Silvers, W.K. , Murphy, G., and Poole, T.W.: Studies on the Η-Y Antigen 
in Rats 85 
Silvers, W . K . : see Elkins, W.L 245 
Simonovä, D . : see Gregorovä, S. et al 301 
Siskind, G.W.: see K i m , Y .T 463 
Shen, F.: see Taylor, B.A 597 
Sherman, M . I . : see Ostrand-Rosenberg, S. et al 127 
Smith, S.M.,Ness, D.B., Talcott, J.A., and Grumet, F.C.: Genetic Control 
of I g M Responses to (T,G)-A — L . H-2 and Ig-1 Linkage 221 
Soderland, C.: see Pious, O.etal 437 
Solheim, B.G.: see Kaakinen, A. et al 205 
Spencer, M.J. , Cherry, J.D., Powell, K.R., Mickey, M.R. , Terasaki, P.L, 
Marcy, S.M., and Sumaya, C.V.: Antibody Responses Following Ru-
bella Immunization Analyzed by H L A and ABO Types 365 
Stallings, V . : see Hyman, R 171 
Stankus, R.P., and Leslie, G.A.: Interspecies and Interantigenic Evaluation 
of a Crossreactive Rat Idiotype 233 
Stanton, T . H . : see Flaherty, L . et al 101 
Streilein, J.W.: Clark Humble: A n Immunolegend for Our Time . . . . 1 
Strosberg, A . D . : Multiple Expression of Rabbit Allotypes: The Tip of 
the Iceberg? 499 
Sumaya, C.V.: see Spencer, M.J. et al 365 
Talcott, J.A.: see Smith, S.M. etal 221 
Taylor, B.A., Shen, F. : Location of Lyb-2 on Mouse Chromosome 4: 
Evidence from Recombinant Inbred Strains 597 
Terasaki, P.I . : see Spencer, M.J. etal 365 
Timpl, R.: see Nowack, H . et al 117 
Thompson, B . H . : see Osofsky, S.G. etal 195 
Thorsby, E.: see Kaakinen, A. et al 205 
V I I I Index 
Tongio, Μ.Μ. : see Hauptmann, G. et al 557 
Vadas, M.A. , Miller, J.F.A.P., Whitelaw, A . M . , and Gamble, J.R.: Regula­
tion by the H-2 Gene Complex of Delayed Type Hypersensitivity . . . 1 3 7 
Vergara, U . : see Pizarro, O.etal 57 
Warner, C M . : see Newton, R.G 449 
Weigert, Μ., and Potter, M . : Antibody Variable-Region Genetics: Summary 
and Abstracts of the Homogeneous Immunoglobulin Workshop V I I . 401 
Wettstein, P.J., and Haughton, G.: The Genetic Control of the Immune 
Response to Murine Histocompatibility Antigens I . The Response to 
H-4 Alloantigens 65 
Whitelaw, A . M . : see Vadas, M . A . et al 137 
Wicker, L.S.: see Harmon, R .G et al 601 
Zeiger, A.R. : see Merryman, G F . et al 373 
Zeuthen, J., Friedrich, U. , Rosen, Α., and Klein, E.: Structural Abnormali­
ties in Chromosome 15 in Cell Lines with Reduced Expression of Beta-2 
Microglobulin 567 
Zink, G.L., and Heyner, S.: The Production of Non-H-2 Histocompatibility 
Alloantibodies in the Mouse 257 
Zinkernagel, R .M. , and Klein, J.: //-2-Associated Specificity of Virus-Im­
mune Cytotoxic Γ Cells from H-2 Mutant and Wild-Type Mice: M523 
(Η-2Κ*α) and M505 (H-2Kbd) Do, M504 (H-2Dda) and M506 (H-2Kfa) 
Do Not Crossreact with Wild-Type H-2K or H-2D 581 
Immunogenetics 4:515 — 522, 1977 Immunogenetics 
(Q 1977 by Springer-Verlag New York Inc. 
Virus-Specific T-Cell Sensitization 
Requirements for Vaccinia Virus-Specific T-Cell Sensitization in vivo* 
Hildegund C.J. Ertl , Rainer H.W. Gerike, and Ulrich Η. Koszinowski 
Hygiene Institut der Universität Göttingen, 
Kreuzbergring 57, D-34 Göttingen, Federal Republic of Germany 
Abstract. Syngeneic, semiallogeneic, or allogeneic spleen lymphocytes were 
transferred into nujnu BALB/c mice, which were infected with vaccinia virus. 
Specific sensitization of transferred thymus-derived cells was determined 
in vivo by mean survival time and virus titer in the spleen six days after 
infection, and in vitro by cell-mediated cytolysis of vaccinia virus-infected 
syngeneic target cells. Virus-specific sensitization took place only after trans-
fer of syngeneic or semiallogeneic spleen lymphocytes; allogeneic lympho-
cytes had no influence on mean survival time or virus titer and showed 
no virus-specific cytolytic activity in vitro. Infection of mice with vaccinia 
virus-strain WR, Elstree, DIs, or DIs-infected syngeneic fibroblasts resulted 
in the generation of virus-specific effector cells, while injection of a high 
amount of inactivated virus particles caused no sensitization. These results 
suggest H-2 homology for production of virus-specific effector cells. Propaga-
tion of virus is not necessary, since early surface antigens, combined with 
syngeneic H-2 antigens, suffice for sensitization of cytolytic Τ lymphocytes. 
Introduction 
The infection of mice with certain viruses such as the L C M virus (Zinkernagel 
and Doherty 1974), poxviruses (Gardner et al 1975, Koszinowski and Thomssen 
1975), or Sendai virus (Ertl and Koszinowski 1976) results in the generation 
of cytolytic Τ lymphocytes, which are able to ki l l in vitro cells infected with 
the virus used for sensitization. The activity of CTLs sensitized against viruses, 
chemically modified cells (Shearer et al 1975), minor histocompatibility antigens 
(Bevan 1975, Gordon et ai 1975) is restricted to attacker- and target-cell homol-
* Abbreviations used in this paper are as follows: CMC, cell-mediated cytolysis; CTL, cytolytic 
Τ lymphocyte; LCM, lymphocytic choriomeningitis; MHC, major histocompatibility complex; 
MST, mean survival time; Τ cell, thymus-derived cell; TCID 5 0 , 50 percent tissue culture infective 
dose. 
516 H.C.J. Ertl etal. 
ogy of the Kov D end of the major histocompatibility complex. Two hypotheses 
have been postulated to explain this H-2 restriction (Doherty and Zinkernagel 
1975) . The physiological interaction theory needs a Τ cell-specific antigen, such 
as a viral surface antigen, and an interaction between identical H-2 structures 
on effector and target cell for recognition and lysis. The altered self theory 
proposes an alteration of H-2 antigenic determinants by virus infection or by 
chemical treatment of cells. Recent findings in chimeric mice (Zinkernagel 
1976) favor the latter theory. Another hypothesis, which proposes a "dual 
recognition" by two T-cell receptors specific for a (modified) K- or Z)-region 
product and a viral surface antigen as a requirement for target cell lysis, should 
be considered. Experiments, which show an inhibition of CMC by antiviral 
antibodies (Koszinowski and Thomssen 1975) are in agreement with this concept. 
The role of H-2 antigenic structures in the sensitization phase is still un­
known. Data reported here were obtained after infection of nujnu BALB/c 
mice which were inoculated with syngeneic, semiallogeneic, or allogeneic spleen 
cells. A specific sensitization, measured in vivo by the mean survival time and 
virus titer in the spleens and in vitro by cytolytic activity of CTL, was dependent 
on the homology of the Κ'and D ends of the H-2 complex between lymphocytes 
and infected cells. 
To obtain further information about the viral antigens for sensitization of 
Τ cells, mice were infected with different virus strains or with inactivated vaccinia 
virus particles. The three strains we used differed in the expression of viral 
surface antigens on infected cells. Early vaccinia surface antigens were sufficient 
for induction of specific CTL in vivo. 
Materials and Methods 
Animals. Mice of the inbred strains C3H ( / / - / ) , DBA/2 (//-2d), A/J (H-2°), and nujnu Balb/c 
(H-2d) at the age of 6-10 weeks were used throughout. They were purchased from Bomholtgard, 
Ry, Denmark. 
Viruses. Vaccinia virus, strain WR and strain Elstree (Lister strain), was propagated in Vero cells 
(monkey kidney cells) and used in a concentration of 105 5 TCID 5 0 /ml. Strain DIs, a conditional 
lethal mutant of the DIE strain (Tagaya etal. 1961), kindly provided by Dr. Y. Ueda, Tokyo, 
Japan, was propagated in 12-day-old fertile chicken eggs at 37°C for 2 days. DIs virus was used 
in a concentration of 1 χ 105 TCID 5 0 /ml. 
Virus Purification. Virus was purified by the method of Joklik (1962). 
Virus Titration. WR and Elstree viruses were titrated on Vero cells. Titration for DIs was done 
on primary chicken fibroblasts (Tagaya etal. 1974). T C I D 5 0 was determined according to the 
method of Reed and Muench (1938). 
Virus Inactivation. Vaccinia virus infectivity was inactivated without loss of antigenicity by incubation 
at 56°C for 120 minutes, interrupted 3 times by a short sonication procedure. 
Target Cells. L-929 fibroblasts (//-2*), obtained from Dr. Lehmann-Grube, Hamburg, and mastocy­
toma P-815-X-2 cells were cultivated in Eagle's minimal essential medium, supplemented with 
10% inactivated calf serum and 100 μg/ml streptomycin and penicillin. 
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Infection and Radioactive Labeling of Target Cells. About 5 χ 10s L-929 cells growing as monolayer 
cultures in glass bottles were incubated with 10 ml vaccinia virus suspension on a rocker platform 
for 2 hours. The virus suspension was then replaced by fresh serum-free medium, and about 
16-18 hours later, cells were trypsinized and incubated with 100 μΟί 5 1 Cr (sodium Chromate, Amers-
ham, Buchler, Braunschweig, 100 to 200 mCi/mg Cr No CJS1P) in a volume of I ml for 1 hour. 
After washing 3 times to remove unbound radioactivity, the cells were used in cytolytic assays. 
P-815 cells were infected with about 5 T C I D 5 0 per cell for 2 hours, washed twice, and labeled 
with 5 l C r for 1 hour. 
Effector Cells. Mice were infected intraperitoneal^ with 10 5 5 T C I D 5 0 (strains WR and Elstree), 
105 T C I D 5 0 (strain DIs), inactivated vaccinia virus (10 1 0 T C I D 5 0 before inactivation), or 1 χ 106 
L-929 cells infected with DIs virus. Nude BALB/c mice were inoculated intravenously with 5 χ 107 
Ficoll-purified spleen cells of C3H, DBA/2, or A/J mice. Six days later, spleens were removed 
and lymphocytes were prepared. 
Cell-Mediated Cytolysis (CMC). The activity of spleen lymphocytes was tested in an 18-hour 
Cr-release assay as described earlier (Koszinowski and Thomssen 1975). Briefly, 5 x l 0 6 spleen 
cells from immunized or normal mice were incubated in microplates with 5 χ 104 normal or vaccinia 
virus-infected 51Cr-labeled target cells in a volume of 0.2 ml at 37°C in a humidified atmosphere 
with 7% C0 2 . Eighteen hours later, supernatant and cell pellet were separated and the percentage 
of Cr release was determined. Percentage of specific lysis was calculated using the following formula: 
Percent specific lysis = Percent Cr release in presence of sensitized lymphocytes 
— Percent Cr release in presence of normal lymphocytes 
Results 
Mean Survival Time of Nude Mice Infected with Vaccinia Virus 
and Inoculated with Syngeneic, Semiallogeneic, 
or Allogeneic Spleen Lymphocytes 
Normal inbred mice survive a vaccinia virus infection without obvious symp­
toms. Nude mice, which are characterized by a congenital lack of thymus-derived 
cells (T cells) died about two weeks after the infection. Inoculation of nude 
mice with 5 χ 107 allogeneic spleen lymphocytes did not prolong the survival 
time. Only syngeneic (or semiallogeneic) spleen cells extended the MST signifi­
cantly (Fig. 1). 
Vaccinia Virus Titer in the Spleens 
of Nude Mice Six Days After Vaccinia Virus Infection 
Groups of three nujnu BALB/c mice were infected with 1 χ 10 5 ' 5 T C I D 5 0 vaccinia 
virus (strain WR) and inoculated with 5 χ 107 syngeneic (DBA/2), semialloge­
neic (A), or allogeneic (C3H) spleen lymphocytes. Six days later, spleens were 
removed and the virus content was estimated by titration on Vero cell mono­
layers. As is shown in Table 1, spleens of nude mice infected with vaccinia 
virus contained about 10 3 - 2 T C I D 5 0 virus. Spleens of infected animals, which 
were inoculated with allogeneic spleen lymphocytes, contained comparable 
amounts of virus, while in spleens of mice which received syngeneic or semiallo-
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Mean Survival Time of H-2d Nude Mice 
After Infection With Vaccinia Virus 
40-
Ε 
Ρ 20 r 
10" 1 — 1 1 — 1 1 — 1 1 —- 1 1 — 1 — 
Vaccinia Vaccinia Vaccinia H-2k Control'1 
Virus Virus Virus Lym. 
+H-2d +H-2k 
Lym. Lym. 
Fig. I . Groups of 15nu/nu BALB/c mice were infected with 1 χ 105 5 T C I D 5 0 vaccinia virus and 
injected simultanously with 5 x l 0 7 allogeneic (C3H), or syngeneic spleen lymphocytes. Controls 
received medium or allogeneic spleen cells alone. "Lethality of untreated mice 
Table 1. Reduction of Vaccinia Virus Titer in the Spleens of Nude Mice11 
Origin of Spleens Virus Titer 
Nude mice {H-21) + 10 5 5 
Nude mice (H-2*) + 10 5· 5 
Nude mice (H-2d) + 10 5 5 
Nude mice (//-2")+105 5 
T C I D 5 0 
TCIDso 
T C I D 5 0 
T C I D 5 0 
Vaccinia virus 
Vaccinia virus Η- A (H-2a) spleen cells 
Vaccinia virus + C3H (H-2k) spleen cells 
Vaccinia virus + DBA/2 (H-21) spleen cells 
103-2 T C I D 5 0 
0 
Ι Ο 2 6 TCID 5 0 
0 
a The vaccinia virus content of spleen cells of three nujnu BALB/c mice infected six days previously 
with 1 χ 10 5· 5 T C I D 5 0 vaccinia virus and injected with 1 χ 107 syngeneic, semiallogeneic, or allogeneic 
spleen lymphocytes was estimated by titration on Vero cells. T C I D 5 0 was determined by the method 
of Reed and Muench (1938). 
geneic spleen lymphocytes, no infectious virus was demonstrable six days after 
infection. 
Cell-Mediated Cytolysis by Lymphocytes of nujnu BALBjc Mice Infected 
with Vaccinia Virus and Substituted with Syngeneic, Semiallogeneic, 
or Allogeneic Spleen Lymphocytes 
Nude mice were not able to produce cytolytic lymphocytes after infection with 
vaccinia virus (Table 2). After transfer of 5 χ 107 allogeneic spleen lymphocytes, 
no virus-specific killer cells against virus-infected target cells were generated; 
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Table 2. Cell-Mediated Cytolysis of Normal and Vaccinia Virus-Infected P-815 Target Cells3 
Origin of Lymphocytes Percent Specific Lysis 
P-815 P-815-Infected 
nu/nu (H-2d) -> vaccinia virus 1.3 ±2.3 4.4 ±4.3 
nu/nu (//-2d) + A {H-T) spleen cells 2.1 ±1.4 4.3 ±2.3 
nu/nu (H-2J) + A (77-2") spleen cells-> vaccinia virus 2.9 ±1.0 17.7±6.1 
nu/nu (Η-2'') + C3H (H-2k) spleen cells 1 l . l ±4.5 0.1 ±4.1 
nu/nu (/7-2'') + C3H (H-2k) spleen cells ->· vaccinia virus 9.8 ±2.4 0.5 ±4.0 
//I///H/ (//-2J) +DBA/2 (//-2") spleen cells 2.6±2.5 0.7 ±2.2 
/7M///M (/Y-2d) + DBA/2 (//-2'') spleen cells -> vaccinia virus 1.3 ±0.6 22.8 ±3.9 
;1 The cytolytic activity of spleen lymphocytes of nu/nu BALB/c mice infected six days previously 
with vaccinia virus and injected with 1 χ 107 syngeneic, semiallogeneic, or allogeneic spleen cells 
was tested on normal and infected P-815 target cells. Assay time: 18 hours. Attacker cell to target 
cell ratio: 100:1. 
only a weak allograft reaction against noninfected P-815 cells could be observed. 
Syngeneic or scmiallogeneic-transferred spleen lymphocytes were able to kill 
only vaccinia virus-infected target cells and had no cytolytic effect on noninfected 
targets. Using normal and vaccinia virus-infected L-929 cells as controls, no 
specific lysis by any group of CTL was observed. 
Role of Different Vaccinia Virus Antigens in Sensitization 
of Antiviral CTL 
Groups of three C3H mice were infected by intraperitoneal injection of 1 χ 105 5 
T C I D 5 0 vaccinia virus, strain WR or Elstree; 1 χ 1 0 5 0 T C I D 5 0 DIs virus; 
heat-inactivated purified virus (1 χ Ι Ο 1 0 T C I D 5 0 before inactivation); or 1 χ 107 
DIs-infected L-929 fibroblasts. 
The three vaccinia virus strains vary in the expression of viral surface anti­
gens. Strain WR, our standard test strain, propagates in mouse cells and ex­
presses early and late surface antigens on the infected cells. Strain Elstree is 
Table 3. CMC by Lymphocytes from Mice Sensitized with Different Vaccinia Virus Strains and 
Viral Antigens3 
Origin of Lymphocytes Percent Specific Lysis of WR-Infected L-929 cells 
C3H-+1 x lO 5 - 5 TCIDJO WR 45.0±2.6 
C 3 H - > l x l 0 5 5 TCrD 5 O Elstree 18.8 ±1.2 
C 3 H - l x l 0 5 ° T C I D 5 0 D I s 27.6 ±2.4 
C3H -* inactivated vaccinia virus I.4±1.9 
C 3 H - L-929, DIs-infected I6.9±1.3 
a The cytolytic activity of spleen lymphocytes of C3H mice infected six days previously with 
1 χ 10 5 , 5 T C I D 5 0 vaccinia virus, strain WR or Elstree; 1 χ Ι Ο 5 0 TCID 5 0 , DIs virus; 1 χ 107 Dis­
infected L-929 cells; or 1 χ 10 1 0 T C I D 5 0 heat-inactivated vaccinia virus (WR) was tested on vaccinia 
virus (WR)-infected L-929 target cells. Assay time: 18 hours. Attacker cell to target cell ratio: 
100:1. 
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defective in the production of early surface antigens. Strain DIs does not propa­
gate in mouse cells but expresses early surface antigens. 
Lymphocytes of mice infected with any of these virus strains were able to 
ki l l vaccinia virus-infected syngeneic target cells (L-929 infected with WR virus, 
Table 3). Also, the injection of DIs virus-infected syngeneic fibroblasts led to 
the production of CTL, while the injection of a high dose of inactivated purified 
virus particles caused no antiviral sensitization of Τ lymphocytes. 
Discussion 
Τ cell-mediated immunity is essential for recovery from poxvirus infection (Blan­
den 1974, Blanden etal. 1975). Macrophages, Β cells, or antibodies do not 
seem to suffice. This was shown in nude mice, which are characterized by 
a congenital lack of thymus-derived lymphocytes. In contrast to normal mice, 
these animals died about one to two weeks after a vaccinia virus infection. 
One important role of sensitized Τ lymphocytes may be the control of virus 
multiplication. Τ cells are probably not able to reduce the number of virus 
particles (Blanden 1971). There is some evidence for virus clearance by macro­
phages, which are activated by sensitized immune lymphocytes (Koszinowski 
et al. 1975). Infected cells, which express early viral surface antigens, are lysable 
by CTL (Koszinowski and Ertl 1976). Early viral surface antigens are synthetized 
about one hour after the infection, while the release of complete infective virus 
particles requires 16 to 20 hours. CTL prevent viral D N A synthesis and virus 
multiplication by attacking cells bearing early viral surface antigens. 
For sensitization of Τ lymphocytes, early viral surface antigens were suffi­
cient, as has been proposed by other authors (Ueda and Tagaya 1973). Infection 
of mice with a high dose of inactivated virus was ineffective, so the stimulus 
for in vivo induction of cytolytic Τ lymphocyte production seems to be the 
virus-infected cell, rather than the free virion. Structural antigens may be essen­
tial for activation of Β cells, which produce neutralizing antibodies. The role 
of late surface antigens, which are expressed on the cell surface during viral 
D N A synthesis, remains unexplained under the experimental conditions, since 
the Elstree strain is only partially defective in production of early surface antigens 
(Ito and Barron 1972). 
The cytolytic activity of Τ cells is characterized by two restrictions. First, 
their action is virus-specific; no crossreactivity occurs between such different 
viruses as L C M virus, vaccinia virus, or Sendai virus (Ertl and Koszinowski 
1976). Second, for efficient lysis, donors of the cytolytic Τ lymphocytes and 
infected cells must be identical at the Κ or D region of the H-2 gene complex, 
since CTL discriminate even point mutations within the Κ region (Doherty 
etal. 1976). H-2 homology is also necessary for the production of virus-specific 
effector cells, as was shown by transfer of syngeneic, semiallogeneic, or allogeneic 
spleen cells into vaccinia virus-infected nude mice. 
These data agree with the modified self hypothesis. One may speculate that 
early viral surface antigens modify H-2 antigenic structures. Recirculating Τ 
lymphocytes control the integrity of H-2 antigens; cells bearing altered or un-
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known (allogeneic or xenogeneic) H-2 antigens lead to clonal expansion of 
Τ lymphocytes, which eliminate these cells. 
Tansfer of syngeneic or semiallogeneic lymphocytes into infected nude mice 
caused increased MST and virus clearance in vivo. In vitro, the transferred 
lymphocytes lysed virus-infected syngeneic target cells. Induction of virus-specific 
CTLs across the H-2 barrier was possible in chimeric mice (Zinkernagel 1976). 
In contrast to lymphocytes, which were transferred into allogeneic nude mice, 
CTLs from chimeric mice are tolerant to the allogeneic target cells, which 
may partially explain the differing results. The in vitro activity of intolerant 
allogeneic sensitized CTLs was rather weak. Neither virus-infected allogeneic 
nor normal or infected syngeneic target cells were lysed. Transfer of allogeneic 
spleen cells had no influence on the progress of virus infection in vivo: MST 
was not prolonged and virus titer in these mice was not reduced significantly. 
One reason for the failure of protection by transferred allogeneic Τ cells may 
be the lack of generation of cytolytic Τ cells. Furthermore, it may indicate 
that collaboration between Τ cells and other immune mechanisms, which cause 
clearance of infective virus under syngeneic or semiallogeneic conditions, is 
impossible in a complete allogeneic situation. 
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